Forbes Focuses on CertiK Skynet Report: Stablecoin Competition Enters Institution-Level Phase with "Security First" Approach
PANews, December 19 – Forbes recently published an in-depth report focusing on the latest developments in the US stablecoin regulatory framework, with a particular emphasis on the "2025 Skynet US Digital Asset Policy Report" released by CertiK, the world's largest Web3 security company. The report cites CertiK's analysis, pointing out that as key policies such as the GENIUS Act continue to advance, the US digital asset industry is transitioning from broad principles to a new stage centered on specific requirements, enforceable regulation, and institutional-level compliance expectations.
CertiK co-founder and CEO Ronghui Gu stated in the report that, in the future, the issuers able to stand out in the stablecoin sector will be those companies that have already established mature, institutional-grade operational systems in reserve management, transparency, and infrastructure. The industry as a whole is also shifting towards a "security-first" approach.
Additionally, Forbes, citing CertiK's report, analyzed that the divergence in regulatory paths between the US and Europe is reshaping the global liquidity landscape for stablecoins: the US regards dollar stablecoins as strategic assets, while the EU's MiCA framework centers on protecting euro monetary sovereignty, gradually forming a "dual-track" stablecoin system. CertiK believes that regulation will not only determine who can issue stablecoins, but also who can compete globally. The real competition is shifting towards long-term operational capabilities across regulatory regimes.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin Trades Around $86K as FOMO Hits Highest Level Since 2024

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions
ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.
Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.
The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.
SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.
The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).
